About Chimigen
Chimigen is a company based in Chengdu (China) founded in 2021.. Chimigen has raised $23.67 million across 1 funding round from investors including SDIC Venture Capital, Casstar and Longpan Investment.
- Headquarter Chengdu, China
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Kaimi Bio Pharmaceuticals (Chengdu) Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$23.67 M (USD)
in 1 rounds
-
Latest Funding Round
$23.67 M (USD), Seed
Jul 18, 2025
-
Investors
SDIC Venture Capital
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Chimigen
Chimigen has successfully raised a total of $23.67M through 1 strategic funding round. The most recent funding activity was a Seed round of $23.67 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $23.7M
-
First Round
First Round
(18 Jul 2025)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Seed - Chimigen | Valuation | SDIC Venture Capital Management |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Chimigen
Chimigen has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include SDIC Venture Capital, Casstar and Longpan Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are managed for innovative company growth.
|
Founded Year | Domain | Location | |
|
Casstar is focused on early-stage investments in hard technology.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Chimigen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Chimigen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Chimigen Comparisons
Competitors of Chimigen
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Chimigen
When was Chimigen founded?
Chimigen was founded in 2021 and raised its 1st funding round 4 years after it was founded.
Where is Chimigen located?
Chimigen is headquartered in Chengdu, China. It is registered at Chengdu, Sichuan, China.
Is Chimigen a funded company?
Chimigen is a funded company, having raised a total of $23.67M across 1 funding round to date. The company's 1st funding round was a Seed of $23.67M, raised on Jul 18, 2025.
What does Chimigen do?
Chimigen was founded in 2021 and is based in Chengdu, China. Focus is placed on biotechnology, specifically the development of immunotherapy solutions targeting viral diseases and tumors. Operations center on a pipeline that includes Chimigen HBV, a chimeric hepatitis B virus vaccine designed to target dendritic cell receptors and stimulate immune responses in patients affected by hepatitis B and related conditions.
Who are Chimigen's investors?
Chimigen has 3 investors. Key investors include SDIC Venture Capital, Casstar, and Longpan Investment.